#United States #Phoenix #Arizona #Humana #HOPCo

HOPCo and Humana Join Forces

The Healthcare Outcomes Performance Company (HOPCo) has made significant strides in the healthcare sector by partnering with Humana to expand its Musculoskeletal (MSK) Population Health Program, particularly for members in Arizona. This collaboration sets the stage for enhanced patient care and management for individuals facing musculoskeletal conditions.

Understanding the Partnership

HOPCo, recognized globally for its innovative approaches in integrated MSK value-based care solutions, aims to improve the quality of care for Humana members through a robust digital platform. This initiative targets eligible members who require tailored MSK care, thereby ensuring they receive appropriate treatment and support.

The partnership centers on deploying HOPCo's unique specialty care platform, which combines advanced analytics with engaging digital tools. This alignment facilitates a collaborative environment among providers and members, ensuring adherence to clinical best practices. The goal is to advance patient health outcomes decisively, making quality care more accessible.

Key Features of HOPCo’s Platform

HOPCo's digital engagement solutions aim to streamline the patient journey significantly. By utilizing their Integrated Care System (ICS), the company guarantees that members diagnosed with MSK disorders receive expedited care management tailored to their specific needs. This is achieved by matching patients with the most suitable providers and treatment settings for their conditions.

One of the standout elements of the HOPCo platform is its ability to integrate in-person, virtual, and hybrid interactions, all supported by MSK clinical experts dedicating themselves to evidence-based protocols. This holistic approach ensures that every interaction along the care continuum is meaningful and directed towards positive health outcomes.

Moreover, HOPCo employs proprietary tools, including myrecovery ®, to fully involve members early in the primary care phase, as well as in consultations with MSK specialists across HOPCo’s statewide Clinically Integrated Network (CIN), known as the HOPCo Specialty Care Network (HSCN).

HSCN distinguishes itself as the only URAC-accredited MSK CIN nationwide, bringing together over 230 MSK specialty physicians focused on maintaining high standards of clinical excellence, incentivized quality metrics, and real-time claims analytics.

HOPCo’s innovative edge is further enhanced by its recent acquisition of Caro Health, a leader in AI-powered digital health solutions. This acquisition reflects HOPCo’s commitment to expanding its digital offerings and remaining competitive in a rapidly evolving healthcare landscape.

Meeting the Needs of Patients and Providers

As articulated by Jason Scalise, MD, Chief Value Officer at HOPCo, the response from payors and risk-bearing entities surrounding their solutions has been overwhelmingly positive. The integrated nature of HOPCo’s services, which encompasses everything from primary care to advanced specialty interventions, proves more effective than disjointed point solutions.

This collaborative model aims to reshape how MSK care is perceived and delivered, aligning all stakeholders towards evidence-based best practices throughout the multitude of patient experiences.

As HOPCo continues to expand its network within Arizona and throughout the U.S., its focus remains on establishing durable MSK care solutions that address the complexities associated with musculoskeletal health. The initiative with Humana marks an important step in this journey, promising a brighter future for patients relying on consistent and quality MSK care.

For further insights into HOPCo’s mission and advancements in healthcare, you can visit their official site at www.hopco.com

Stay updated with HOPCo's latest initiatives on platforms such as LinkedIn, Instagram, and Facebook.